Former NASA engineer Dave McKissock, 65, is speaking publicly about living with early-stage Alzheimer’s, diagnosed nearly two years ago. He is pushing for more extensive testing and taking FDA-approved LEQEMBI to slow cognitive decline, while sharing advice for patients and care partners.
Reporting from 1 identified publisher for this event.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 435 of 22954
Same format. Every time.
Continue reading — sign in or create a free account with